Cubist Systematic Strategies’s BioAtla BCAB Stock Holding History

Cubist Systematic Strategies’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-156	Closed	-$13.7K	–	2977
2024 Q3	$13.7K	Buy	+156	New	+$13.1K	﹤0.01%	2838
2023 Q3	–	Sell	-890	Closed	-$133K	–	3341
2023 Q2	$133K	Buy	890 +11	+1%	+$1.89K	﹤0.01%	2928
2023 Q1	$118K	Buy	879 +347	+65%	+$62.5K	﹤0.01%	3407
2022 Q4	$220K	Buy	532 +197	+59%	+$81.7K	﹤0.01%	3526
2022 Q3	$129K	Sell	335 -308	-48%	-$101K	﹤0.01%	3931
2022 Q2	$92K	Sell	643 -782	-55%	-$124K	﹤0.01%	3995
2022 Q1	$356K	Buy	1,425 +359	+34%	+$150K	﹤0.01%	2738
2021 Q4	$1.05M	Buy	1,066 +430	+68%	+$550K	0.01%	1878
2021 Q3	$935K	Buy	+636	New	+$1.24M	0.01%	1577

Other funds holding BCAB

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Cubist Systematic Strategies's BCAB Position: Q4 2024 in Review

Cubist Systematic Strategies sold out of BioAtla (BCAB) in Q4 2024, closing a stake of 156 shares — an estimated $13.7K sold.

Cubist Systematic Strategies first reported a position in BCAB in Q3 2021 and held it in 9 quarters. The position peaked at $1.05M in Q4 2021. 67 funds tracked by Wall St. Rank hold BCAB as of Q4 2024.

Cubist Systematic Strategies reported no remaining BioAtla position as of Q4 2024 after selling out during the quarter.
Cubist Systematic Strategies sold 156 BioAtla shares in Q4 2024, an estimated $13.7K.
Cubist Systematic Strategies first reported a position in BioAtla in Q3 2021 and held it in 9 quarters.
Cubist Systematic Strategies's BioAtla position peaked at $1.05M in Q4 2021.
67 funds tracked by Wall St. Rank held BioAtla as of Q4 2024.

Based on Cubist Systematic Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.